BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11905923)

  • 1. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
    Huggins C; Hodges CV
    J Urol; 2002 Feb; 167(2 Pt 2):948-51; discussion 952. PubMed ID: 11905923
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate by Charles Huggins and Clarence V. Hodges.
    Glina S; Rivero MA; Morales A; Morgentaler A
    J Sex Med; 2010 Feb; 7(2 Pt 1):640-4. PubMed ID: 20492413
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.
    Huggins C; Hodges CV
    CA Cancer J Clin; 1972; 22(4):232-40. PubMed ID: 4625049
    [No Abstract]   [Full Text] [Related]  

  • 4. Artist, Rediscovered: Images and Ethics of Early Prostate Cancer Screening.
    Wyner LM
    JAMA; 2019 Apr; 321(13):1236-1238. PubMed ID: 30938779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostatic cancer: indications for hormone therapy].
    Bruntsch U; Gallmeier WM
    MMW Munch Med Wochenschr; 1979 Mar; 121(9):300-2. PubMed ID: 85258
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
    Huggins C; Hodges CV
    J Urol; 2002 Jul; 168(1):9-12. PubMed ID: 12050481
    [No Abstract]   [Full Text] [Related]  

  • 7. THE TREATMENT OF METASTATIC PROSTATIC CANCER WITH DITHIZONE (DIPHENYLTHIOCARBAZONE).
    MACKENZIE AR; BHISITKUL IP; WHITMORE WF
    Invest Urol; 1963 Nov; 1():229-37. PubMed ID: 14102153
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilateral adrenalectomy for advanced prostatic carcinoma.
    Schoonees R; Schalch DS; Reynoso G; Murphy GP
    J Urol; 1972 Jul; 108(1):123-5. PubMed ID: 5033992
    [No Abstract]   [Full Text] [Related]  

  • 9. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES.
    SCHIRMER HK; RICHARDS GJ
    J Urol; 1964 Dec; 92():714-20. PubMed ID: 14241206
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenocarcinoma of the prostate gland.
    Boxer RJ
    Urol Surv; 1977 Jun; 27(3):75-94. PubMed ID: 331648
    [No Abstract]   [Full Text] [Related]  

  • 11. [POSSIBILITIES OF "GUIDED" ENDOCRINE-SURGICAL TREATMENT IN CANCER OF THE PROSTATE].
    GIANNONI R; ZINI S; MARCELLI G
    Arch Ital Urol; 1964 Apr; 36():423-40. PubMed ID: 14146744
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypophysectomy for reactivated disseminated prostatic carcinoma.
    Schoonees R; Bourke RS; Reynoso G; Murphy GP; Sćhalch DS
    S Afr Med J; 1972 Sep; 46(36):1278-85. PubMed ID: 4118726
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of prostatic carcinoma from the endocrinologic viewpoint].
    Rothauge CF; Wildberger JE; Szasz G; Graef V
    Urologe; 1969; 8(5):237-9. PubMed ID: 5359388
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum markers as a predictor of response duration and patient survival after hormonal therapy for metastatic carcinoma of the prostate.
    Smith JA; Lange PH; Janknegt RA; Abbou CC; deGery A
    J Urol; 1997 Apr; 157(4):1329-34. PubMed ID: 9120932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis and treatment of prostatic carcinoma].
    Klug W
    Zentralbl Chir; 1968 Mar; 93(10):362-6. PubMed ID: 5674208
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine-induced regression of cancers.
    Huggins C
    Am J Surg; 1978 Aug; 136(2):233-8. PubMed ID: 150802
    [No Abstract]   [Full Text] [Related]  

  • 17. [Late results of treatment of prostatic cancer].
    Hanschke HJ; König K; Caspar W
    Dtsch Med Wochenschr; 1968 Nov; 93(47):2271-4. PubMed ID: 5686345
    [No Abstract]   [Full Text] [Related]  

  • 18. Twin Cities--the highest incidence of prostatic cancer in the nation.
    Godec CJ; Bates H; Fencl RJ; Cass AS
    Minn Med; 1982 Oct; 65(10):611-5. PubMed ID: 6757700
    [No Abstract]   [Full Text] [Related]  

  • 19. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
    Bhanalaph T; Varkarakis MJ; Murphy GP
    Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
    [No Abstract]   [Full Text] [Related]  

  • 20. Unpredictable fluctuations in serum acid phosphatase activity in prostatic cancer.
    Brenckman WD; Lastinger LB; Sedor F
    JAMA; 1981 Jun; 245(24):2501-4. PubMed ID: 7230488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.